This grant, offered by the National Institutes of Health (NIH), is for the purpose of supporting vital research focused on better defining the M. Tuberculosis granuloma. As the hallmark structure of pulmonary tuberculosis (TB), understanding the granuloma’s precise role in disease progression and treatment outcomes is critical. This initiative aims to build a much-needed knowledge base concerning the granuloma’s involvement in TB. Such improved understanding is fundamental, serving as a direct pathway to developing significantly more effective and advanced therapeutic approaches. The ultimate goal is to enhance our capacity to manage and treat tuberculosis more successfully.
Opportunity ID: 329259
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-20-057 |
Funding Opportunity Title: | Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 29, 2020 |
Last Updated Date: | Sep 29, 2020 |
Original Closing Date for Applications: | Feb 22, 2021 |
Current Closing Date for Applications: | Feb 22, 2021 |
Archive Date: | Mar 30, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Special district governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments Private institutions of higher education State governments County governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | To support research to better define the role of the granuloma, the hallmark structure of pulmonary tuberculosis (TB), in TB disease and disease outcomes. Improved understanding of the granuloma will provide a much-needed knowledge base for the development of improved therapeutic approaches. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-057.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00263626 | Jan 22, 2021 | Feb 22, 2021 | View |
Package 1
Mandatory forms
329259 RR_SF424_2_0-2.0.pdf
329259 PHS398_CoverPageSupplement_5_0-5.0.pdf
329259 RR_OtherProjectInfo_1_4-1.4.pdf
329259 PerformanceSite_2_0-2.0.pdf
329259 RR_KeyPersonExpanded_2_0-2.0.pdf
329259 PHS398_ResearchPlan_4_0-4.0.pdf
329259 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
329259 RR_Budget_1_4-1.4.pdf
329259 RR_SubawardBudget30_1_4-1.4.pdf
329259 PHS398_ModularBudget_1_2-1.2.pdf
329259 PHS_AssignmentRequestForm_3_0-3.0.pdf